Codeine O-demethylation co-segregates with polymorphic debrisoquine hydroxylation
- PMID: 2611086
- PMCID: PMC1380034
- DOI: 10.1111/j.1365-2125.1989.tb03556.x
Codeine O-demethylation co-segregates with polymorphic debrisoquine hydroxylation
Abstract
1. A single oral dose of codeine (25 mg) was given to 132 healthy Swedish Caucasians who had previously been phenotyped with respect to debrisoquine hydroxylation. The 'metabolic ratios' (MR) in urine of codeine O-demethylation (codeine/(morphine (M) + morphine-3- and 6-glucuronides (M3G and M6G) + normorphine], N-demethylation (codeine/(norcodeine (NC) + norcodeine glucuronide + normorphine (NM]) and glucuronidation (codeine/codeine-6-glucuronide (C6G] were calculated following h.p.l.c. analysis of urine samples collected over 8 h. 2. There was a significant correlation between the log MR for debrisoquine hydroxylation and the log MR for codeine O-demethylation (rs = 0.77, P less than 0.001). The poor debrisoquine hydroxylators had MRs of codeine O-demethylation between 8.3 and 55.1, while the values for extensive hydroxylators were between 0.4 and 5.5. 3. The poor debrisoquine hydroxylators excreted significantly less M, M3G, M6G and NM, while the urinary recovery of C6G and NC was significantly higher in these subjects compared to the extensive hydroxylators. 4. The MRs for glucuronidation and N-demethylation did not exhibit a bimodal distribution, and were not related to the MR of debrisoquine hydroxylation. 5. No associations were found between sex, body-weight, smoking habits, age, urine volume or urine pH and the O-demethylation of codeine. 6. The O-demethylation of codeine to form M appears to be under the same polymorphic genetic control as the 4-hydroxylation of debrisoquine.
Similar articles
-
Pharmacokinetics of codeine and its metabolites in Caucasian healthy volunteers: comparisons between extensive and poor hydroxylators of debrisoquine.Br J Clin Pharmacol. 1991 Jun;31(6):635-42. doi: 10.1111/j.1365-2125.1991.tb05585.x. Br J Clin Pharmacol. 1991. PMID: 1867957 Free PMC article.
-
Interindividual and interethnic differences in the demethylation and glucuronidation of codeine.Br J Clin Pharmacol. 1989 Dec;28(6):629-37. doi: 10.1111/j.1365-2125.1989.tb03555.x. Br J Clin Pharmacol. 1989. PMID: 2611085 Free PMC article.
-
The effect of codeine on gastrointestinal transit in extensive and poor metabolisers of debrisoquine.Eur J Clin Pharmacol. 1997;53(2):145-8. doi: 10.1007/s002280050353. Eur J Clin Pharmacol. 1997. PMID: 9403287 Clinical Trial.
-
Inhibition of desipramine 2-hydroxylation by quinidine and quinine in rapid and slow debrisoquine hydroxylators.Psychopharmacol Ser. 1989;7:201-5. doi: 10.1007/978-3-642-74430-3_21. Psychopharmacol Ser. 1989. PMID: 2687858 Review. No abstract available.
-
The polymorphic oxidation of beta-adrenoceptor antagonists. Clinical pharmacokinetic considerations.Clin Pharmacokinet. 1986 Jan-Feb;11(1):1-17. doi: 10.2165/00003088-198611010-00001. Clin Pharmacokinet. 1986. PMID: 2868819 Review.
Cited by
-
Strategies and molecular probes to investigate the role of cytochrome P450 in drug metabolism: focus on in vitro studies.Clin Pharmacokinet. 2003;42(2):153-78. doi: 10.2165/00003088-200342020-00004. Clin Pharmacokinet. 2003. PMID: 12537515 Review.
-
Pharmacogenetic phenotyping and genotyping. Present status and future potential.Clin Pharmacokinet. 1994 Jan;26(1):59-70. doi: 10.2165/00003088-199426010-00005. Clin Pharmacokinet. 1994. PMID: 8137598 Review.
-
Pharmacokinetic changes in the elderly. Do they contribute to drug abuse and dependence?Clin Pharmacokinet. 1996 Nov;31(5):372-85. doi: 10.2165/00003088-199631050-00004. Clin Pharmacokinet. 1996. PMID: 9118585 Review.
-
The effect of quinidine on the analgesic effect of codeine.Eur J Clin Pharmacol. 1992;42(6):587-91. doi: 10.1007/BF00265920. Eur J Clin Pharmacol. 1992. PMID: 1623898 Clinical Trial.
-
Analgesic effect and plasma concentrations of codeine and morphine after two dose levels of codeine following oral surgery.Eur J Clin Pharmacol. 1993;44(4):319-23. doi: 10.1007/BF00316466. Eur J Clin Pharmacol. 1993. PMID: 8513842 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources